Qrono Inc

Headquarters

Pittsburgh, PA

Qrono Inc. is developing immunotherapies using the Eloquent platform to target antigen-presenting cells and macrophages for cancer treatment. The company focuses on mathematically optimized polymer particles to deliver agents at controlled rates to specific cells.

• AdaptimmuneAdaptimmune focuses on designing and delivering novel cancer immunotherapy products, specifically T-cell receptor (TCR) T-cell therapies. The company utilizes a proprietary TCR platform to identify cancer targets and genetically engineer TCRs to recognize and attack these targets, producing autologous T-cell treatments. Adaptimmune has a preclinical pipeline with multiple cell therapy approaches and manufactures products at its Navy Yard facility in Philadelphia, PA.541714PHILADELPHIA, PA
• Duo OncologyDuo Oncology is a clinical-stage biotechnology company that develops and manufactures ultrasmall nanomedicines for cancer treatment. The company's proprietary platform creates nanomedicines that deliver dual anti-cancer therapies directly to tumors, with a lead product DUO-207 for pancreatic cancer advancing to clinical trials.PITTSBURGH, PA
• Churchill PharmaceuticalsChurchill Pharmaceuticals is focused on developing and delivering valued therapies that improve trusted pharmaceuticals for patients living with cancer. The company is a rapidly growing, privately funded company based in the greater Philadelphia area with a lead product for genitourinary cancers and a pipeline including oral cancer compounds utilizing SoluMatrix Fine Particle Technology®.KING OF PRUSSIA, PA
• iCeuticaiCeutica is a pharmaceutical research and development company that applies its proprietary SoluMatrix Fine Particle Technology to create new branded medicines with improved efficacy, better side effect profiles, and more convenient dosing. The company works with pharmaceutical partners and advances its own pipeline of product candidates for pain and inflammation, oncology, and respiratory diseases.KING OF PRUSSIA, PA